Skip to content

HNGE HNGE Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price at other companies

Globus Medical logo
Globus MedicalGMED

Other financials

Income statement

See full
Revenue$182.3M+47.2%
Gross profit$154.2M+53.9%
Operating income$32.1M+144%
Net income$35.1M+105%
EPS (diluted)$0.41-68.7%

Balance sheet

See full
Cash & equivalents$188.1M-35.2%
Total debt$7.0M
Total equity$111.7M+136%
Total assets$728.8M

Cash flow

See full
Operating cash flow$43.1M+775%
CapEx$83.0K+62.7%
Free cash flow$43.0M+782%

Valuation

See full
Market cap$5.37B
Enterprise value$5.19B
P/S8.3×

Profitability

See full
Gross margin80.8%+1.5pp
Operating margin-85.8%
Net margin-83.9%
FCF margin32.3%

Returns & leverage

See full
Return on equity551.8%
Debt / equity0.1×
Current ratio1.3×

Where this comes from

Reported directly by HNGE in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice.

The official record: HNGE’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about HNGE's share-based compensation arrangement by share-based payment award, options, exercisable, weighted average exercise price.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is HNGE's share-based compensation arrangement by share-based payment award, options, exercisable, weighted average exercise price?
HNGE (HNGE) reported share-based compensation arrangement by share-based payment award, options, exercisable, weighted average exercise price of $1.68 in Q1 2026.